Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
Clinical trial NCT05145127 · RECRUITING
Trial details
- NCT number
- NCT05145127
- Sponsor
- Pfizer
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-17
- Primary completion
- 2030-07-31
- Enrollment
- 245
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.